Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2025-12-24 @ 11:02 PM
NCT ID:
NCT03276169
Eligibility Criteria:
Inclusion Criteria:
* persistent atrial fibrillation episode occurs in the patient that lasting longer than one year,
* atrial fibrillation cannot be prevented in patients who orally take class I and III antiarrhythmic drugs,
* and patient age is \<80 years.
Exclusion Criteria:
* patients with previous history of atrial fibrillation ablation, atrial thrombosis, or valvular heart disease (moderate and severe valvular stenosis, severe valvular regurgitation),
* patients who underwent prosthetic heart valve replacement,
* pregnant women,
* patients with existing liver and kidney disease, malignant tumors or hematological system diseases.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
80 Years
Study:
NCT03276169
Study Brief:
Protocol Section:
NCT03276169